Interventional Cardiology And Peripheral Vascular Devices Market Size, Share, Growth and Forecast 2017 to 2025
September 23, 2019 by Johnson Paul
The latest market report published by Credence Research, Inc. “Interventional Cardiology and Peripheral Vascular Devices Market By Product (Angioplasty Stents, Angioplasty Balloon Catheter, Guidewires, Vascular Closure Devices, Peripheral Embolic Protection Devices, Atherectomy Devices, Endovascular Stent Grafts, Vascular Grafts, Thrombectomy Devices, Inferior Vena Cava Filter) - Growth, Future Prospects and Competitive Analysis, 2017-2025,” the worldwide market for interventional cardiology and peripheral vascular devices was valued at US$ 14.53 billion in 2016 and increased to CAGR by 8.8%.
Browse the full report at https://www.credenceresearch.com/report/interventional-cardiology-peripheral-vascular-devices-market
Interventional cardiology and peripheral vascular therapy is a preferred option to traditional open surgery for cardiovascular disease therapy. Interventional methods are gaining recognition in the medical fraternity for the therapy of cardiac illnesses and peripheral vascular diseases in order to be secure and effective in terms of therapy outcomes. The market for interventional cardiology and peripheral vascular devices is anticipated to see steady growth owing to increased private satisfaction among patients with coronary heart illness and peripheral vascular disorders. The future interventional strategy will continue to grow as fresh techniques take over open surgery.
Global interventional cardiology and peripheral vascular device market growth is fuelled by rising cardiovascular disease and ensuing elevated mortality rates worldwide since heart disease caused 633,000 deaths among Americans in 2015, according to information reported by the National Center for Health Statistics. Peripheral arterial disease affects more than 10 million patients, causing further discomfort and severe complications. Sedentary lifestyles with fat-rich dietary habits, increased consumption of tobacco and alcohol, and stress act as a trigger for cardiovascular disease. In addition to these, two other significant risk factors for cardiovascular diseases are diabetes and obesity, which are also on the increase and are likely to increase market growth. The adoption of changing technology in healthcare centres, an growing amount of cardiac catheterization labs and an growing fund for continuing cardiovascular studies have a beneficial effect on the development of the industry.
Based on the type of interventional cardiology and peripheral vascular devices, the market was dominated by angioplasty stents and angioplasty catheters in 2016. Increasing proclivity to minimally invasive surgical processes, the application of angioplasty stents and catheters in cardiac processes is accelerating. This functions as the main driving force for profitable market growth owing to reduced complications and quicker recovery.
On the basis of regional segmentation, North America leads the global interventional cardiology and peripheral vascular devices market owing to advanced healthcare infrastructure, increasing healthcare expenditure in order to develop innovative treatment and growing health awareness in people. Rising prevalence of cardiovascular disorders owing to constantly changing lifestyle and increasing geriatric population primarily drive the interventional cardiology and peripheral vascular devices market. Gradually rising number of percutaneous coronary intervention (PCI) centers in the United States also plays as key driver of interventional cardiology and peripheral vascular devices market. The interventional cardiology and peripheral vascular devices market in Asia Pacific region is expected to witness substantial growth due to developing economies and rising initiatives for betterment of health and rising health consciousness.
Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/58895
Market Competition Assessment:
The major industry players of interventional cardiology and peripheral vascular devices market having interventional cardiology and peripheral vascular devices market includes Cook Medical, Inc., Boston Scientific Corporation, Cardinal Health, Inc., St. Jude Medical, Abbott Laboratories, C. R. Bard, Inc., Medtronic plc., Edwards Lifesciences Corporation, Terumo Corporation, B. Braun Melsungen AG, Baxter International Inc., 3M Company, and other notable players.
Key Market Movements:
By Product Type
By Geography Segment (2017–2027; US$ Bn)